Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Azn crawled date : 2022 - 03 - 02 save search
New Drug Delivery Systems Market 2022-2026 | Rising Prevalence Of Chronic Diseases to Boost Growth | Technavio
Published: 2022-03-02 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -6.92%
H: 1.86%
C: 1.86%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
BAX | $40.93 -0.22% 0.0% 2.2M
|
Health Technology
|
| O: 0.28%
H: 0.54%
C: -0.33%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -2.63%
H: 0.9%
C: -0.3%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 2.3%
H: 0.0%
C: 0.0%
new drug drug liver system disease growth drug delivery
Genprex Announces First Patient Dosed in Phase 1/2 Acclaim-1 Clinical Trial of REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
Published: 2022-03-02 (Crawled : 14:00) - biospace.com/
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.37%
H: 2.02%
C: 2.02%
GNPX | $2.31 6.77% 20K
|
Health Technology
|
| O: 3.95%
H: 5.06%
C: -7.17%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
tagrisso gene therapy trial cel lung cancer phase 1 therapy cancer
JAK Inhibitors Market to Grow by USD 12.05 billion | Increasing Number of Awareness Campaigns to Boost Growth | Technavio
Published: 2022-03-01 (Crawled : 00:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 0.37%
H: 2.02%
C: 2.02%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
ALPMY | News | $9.49 -1.11% 480K
|
Manufacturing
|
| O: -1.17%
H: 0.68%
C: 0.68%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.55%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.22%
H: 2.4%
C: 1.27%
GLPG | News | $28.78 -2.28% -2.33% 140K
|
Health Technology
|
| O: -2.66%
H: 0.35%
C: -1.83%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 6.03%
H: 13.88%
C: 12.71%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.62%
H: 0.0%
C: 0.0%
growth
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.